FDA Approves Eli Lilly's Onswik Once-Weekly Insulin for Type 2 Diabetes
The US regulator granted approval for the drugmaker's basal insulin therapy, providing patients with an alternative to daily injections.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- FDA
- Eli Lilly
- Onswik